1. Home
  2. CARE vs MYGN Comparison

CARE vs MYGN Comparison

Compare CARE & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$24.27

Market Cap

507.1M

Sector

Finance

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.13

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARE
MYGN
Founded
1974
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.1M
444.2M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
CARE
MYGN
Price
$24.27
$5.13
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$25.00
$7.64
AVG Volume (30 Days)
310.6K
1.2M
Earning Date
04-24-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
30.19
N/A
EPS
1.38
N/A
Revenue
$20,315,000.00
$771,400,000.00
Revenue This Year
$12.50
$6.89
Revenue Next Year
$11.82
$5.35
P/E Ratio
$17.57
N/A
Revenue Growth
4.65
2.33
52 Week Low
$14.85
$3.76
52 Week High
$24.86
$8.59

Technical Indicators

Market Signals
Indicator
CARE
MYGN
Relative Strength Index (RSI) 72.32 58.22
Support Level $19.49 $4.25
Resistance Level $24.86 $5.60
Average True Range (ATR) 0.44 0.29
MACD 0.02 0.08
Stochastic Oscillator 68.46 77.62

Price Performance

Historical Comparison
CARE
MYGN

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: